RecruitingNCT05179616
Pforzheim Tricuspid Valve Registry - Outcomes of Percutaneous Tricuspid Valve Repair
Pforzheim Tricuspid Valve Registry: A Real-world Observational Trial Evaluating Outcomes in Patients Treated With the Abbott TriClip™ Device in Helios Klinikum Pforzheim
Sponsor
Helios Klinikum Pforzheim
Enrollment
200 participants
Start Date
Nov 30, 2020
Study Type
OBSERVATIONAL
Conditions
Summary
The Pforzheim Tricuspid Valve Registry study is designed to confirm the safety and performance of the TriClip™ device in a contemporary real-world setting in critically ill patients. The observational trial is a prospective, single arm, open-label, single-center, post market registry.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Subjects (\>=18 years age) have severe tricuspid regurgitation and are symptomatic despite medical therapy.
- Subjects eligible to receive the TriClip™
- Subjects must provide written informed consent prior to study procedure.
Exclusion Criteria1
- Subjects participating in another clinical study that may impact the follow-up or results of this study.
Interventions
PROCEDURETranscatheter edge-to-edge tricuspid valve repair
Percutaneous edge to edge repair of tricuspid valve using the TriClip system
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05179616
Related Trials
Evaluation of the Impact of Interventional Treatments for Symptomatic, Severe Tricuspid Valve Insufficiency on Renal Integrity and Function, as Well as on Physical Function and Activity in Older Adults.
NCT074641061 location
Incidence and Evolution of Heart-lung Interaction in Acute Respiratory Distress Syndrome
NCT074508461 location
Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future
NCT060391767 locations
Feasibility Trial for a Right Ventricular Failure Platform Trial
NCT065704735 locations
Cholate Clearance in Fontan and Heart Failure
NCT070091321 location